Fundz

Moleculight Secures Financing From Bdc Canada And Igan Partners To Support Its Commercial Expansion

PRIVATEAug 11, 2022

Round Type

Funding Round

TorontoBiotechnologyHealth Care

Description

MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of wounds containing elevated bacterial loads, announced that it has completed a financing with BDC Capital and iGan Ventures. The funds are to support MolecuLight's continued global expansion to meet growing customer demand for its MolecuLight i:X® and DXTM devices. Leonard Kofman and Jody Staggs, Managing Director of SWK Holdings will join MolecuLight's Board of Directors as observers.

Quick answer

MolecuLight raised an undisclosed amount in a Funding Round round, dated August 11, 2022. MolecuLight is based in Toronto, Ontario, Canada.

How much did MolecuLight raise?
MolecuLight raised an undisclosed amount in a Funding Round round on August 11, 2022.
What does MolecuLight do?
MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets.
Where is MolecuLight based and how big is it?
MolecuLight is based in Toronto, Ontario, Canada. Fundz records about 33 employees.
Who are the decision-makers at MolecuLight?
Fundz holds 2 contacts at MolecuLight, including the CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as MolecuLight that raised within 45 days of this round, from Fundz verified event records.

  • Endovia Health Sciences, Inc. raised an undisclosed amount (Funding Round) on September 23, 2022.
  • Novabay raised $3.3M (Seed) on September 23, 2022.
  • CASI Pharmaceuticals raised an undisclosed amount on September 23, 2022.
  • Leuko raised $5M (Series A) on September 23, 2022.
  • Surge raised $2.6M (Seed) on September 23, 2022.
  • Roca Therapeutics raised an undisclosed amount (Seed) on September 22, 2022.

Who to call at MolecuLight, and when

A new round usually means MolecuLight is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MolecuLight raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MolecuLight, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MolecuLight. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MolecuLight

Location

425 University Ave, Suite 700

Toronto, Ontario, Canada

About

MolecuLight Inc. a privately-owned medical imaging company that has developed and is commercializing its proprietary fluorescent imaging platform technology in multiple clinical markets. MolecuLight’s suite of commercially released devices, including the MolecuLight i:X® and DX™ fluorescence imaging systems and their accessories, provide point-of-care handheld imaging devices for the global wound care market for the real-time detection of wounds containing elevated bacterial burden > 10^4 CFU/g (when used with clinical signs and symptoms) and for digital wound measurement #moleculight

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MolecuLight raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsAnil A., CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for MolecuLight's next move

See what Strategic adds

MolecuLight raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.